We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BPMC market cap is 5.59B. The company's latest EPS is USD -8.2797 and P/E is -11.05.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.98M | 38.78M | 63.29M | 57.57M | 56.57M |
| Operating Income | -124.28M | -149.8M | -124.21M | -129.28M | -128.98M |
| Net Income | -133.16M | -158.65M | -129.56M | -132.79M | -133.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.51M | 793.74M | 180.08M | 204.04M | 249.38M |
| Operating Income | -361.33M | 308.71M | -641.98M | -537.52M | -486.28M |
| Net Income | -347.69M | 313.88M | -644.09M | -557.52M | -506.98M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.46B | 1.35B | 1.22B | 1.11B | 1.11B |
| Total Liabilities | 818.09M | 835.23M | 806.07M | 795.32M | 902.69M |
| Total Equity | 640.31M | 514.68M | 414.3M | 311.13M | 202.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 707.69M | 1.72B | 1.25B | 1.35B | 1.05B |
| Total Liabilities | 243.34M | 248.31M | 281.49M | 835.23M | 918.64M |
| Total Equity | 464.36M | 1.47B | 970.74M | 514.68M | 130.61M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -380.87M | -502.28M | -122.96M | -253.44M | -357.92M |
| Investing | -96.26M | -149.54M | 172.79M | 204.86M | 195.27M |
| Financing | 559.32M | 561.81M | N/A | 5.3M | 103.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -278.02M | 387.04M | -298.65M | -502.28M | -436.85M |
| Investing | -16.47M | -434.25M | -225.86M | -149.54M | 274.04M |
| Financing | 340.64M | 617.76M | 50.72M | 561.81M | 119.23M |
| Market Cap | 5.59B |
| Price to Earnings Ratio | -11.05 |
| Price to Sales Ratio | 22.45 |
| Price to Cash Ratio | 78.55 |
| Price to Book Ratio | 42.87 |
| Dividend Yield | - |
| Shares Outstanding | 61.23M |
| Average Volume (1 week) | 696.26k |
| Average Volume (1 Month) | 620.33k |
| 52 Week Change | 78.12% |
| 52 Week High | 101.00 |
| 52 Week Low | 43.89 |
| Spread (Intraday) | 32.91 (33.61%) |
| Company Name | Blueprint Medicines Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.blueprintmedicines.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
